AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.00 Decreased By ▼ -0.53 (-0.41%)
BOP 6.76 Increased By ▲ 0.08 (1.2%)
CNERGY 4.50 Decreased By ▼ -0.13 (-2.81%)
DCL 8.70 Decreased By ▼ -0.24 (-2.68%)
DFML 41.00 Decreased By ▼ -0.69 (-1.66%)
DGKC 81.30 Decreased By ▼ -2.47 (-2.95%)
FCCL 32.68 Decreased By ▼ -0.09 (-0.27%)
FFBL 74.25 Decreased By ▼ -1.22 (-1.62%)
FFL 11.75 Increased By ▲ 0.28 (2.44%)
HUBC 110.03 Decreased By ▼ -0.52 (-0.47%)
HUMNL 13.80 Decreased By ▼ -0.76 (-5.22%)
KEL 5.29 Decreased By ▼ -0.10 (-1.86%)
KOSM 7.63 Decreased By ▼ -0.77 (-9.17%)
MLCF 38.35 Decreased By ▼ -1.44 (-3.62%)
NBP 63.70 Increased By ▲ 3.41 (5.66%)
OGDC 194.88 Decreased By ▼ -4.78 (-2.39%)
PAEL 25.75 Decreased By ▼ -0.90 (-3.38%)
PIBTL 7.37 Decreased By ▼ -0.29 (-3.79%)
PPL 155.74 Decreased By ▼ -2.18 (-1.38%)
PRL 25.70 Decreased By ▼ -1.03 (-3.85%)
PTC 17.56 Decreased By ▼ -0.90 (-4.88%)
SEARL 78.71 Decreased By ▼ -3.73 (-4.52%)
TELE 7.88 Decreased By ▼ -0.43 (-5.17%)
TOMCL 33.61 Decreased By ▼ -0.90 (-2.61%)
TPLP 8.41 Decreased By ▼ -0.65 (-7.17%)
TREET 16.26 Decreased By ▼ -1.21 (-6.93%)
TRG 58.60 Decreased By ▼ -2.72 (-4.44%)
UNITY 27.51 Increased By ▲ 0.08 (0.29%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,450 Increased By 43.4 (0.42%)
BR30 31,209 Decreased By -504.2 (-1.59%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)

MOSCOW: Russia on Tuesday admitted that its homegrown Sputnik V coronavirus vaccine had not yet been approved by the World Health Organization because Russian authorities had not provided enough data.

In August last year, Sputnik V became the world's first approved coronavirus vaccine, when Russian authorities gave it the green light for domestic use ahead of large-scale clinical trials.

"We still haven't provided certain information that needs to be provided for certification because we had a different understanding of what information it had to be and how it should be provided," Kremlin spokesman Dmitry Peskov told reporters.

"We have different standards."

But Peskov said Russia is "gradually, let's say, adapting to these requirements."

While officials sparked concerns over the fast-track process, the jab was since declared safe and more than 90 percent effective in a report published by leading medical journal The Lancet.

But neither the US nor EU medicines watchdogs have so far granted authorisation for Sputnik V, which has been used in Russia and a host of other countries since late last year.

Russia's Sputnik V vaccine shows 96.3% COVID-19 efficacy in Belarus

The WHO last month said it had restarted the certification process that could grant emergency authorisation for Sputnik V after delaying the process for several months but said it still needed "the full dossier on Sputnik".

At home, Russian authorities have faced a vaccine-sceptic population that has seen just 42 percent of Russians fully inoculated.

A Twitter account associated with jailed opposition leader Alexei Navalny on Tuesday blamed the delayed WHO certification process on the Russian authorities and said that it had contributed to vaccine-scepticism at home.

"People are dying and they are sorting through paper," the account tweeted.

The WHO has so far granted emergency authorisations to Covid-19 shots Pfizer-BioNTech, Moderna, AstraZeneca, Johnson&Johnson, Sinopharm, Sinovac and India's Bharat Biotech.

Comments

Comments are closed.